MedPath

Cycled phototherapy in treatment of neontal jaundice

Phase 1
Recruiting
Conditions
eonatal Jaundice.
???? ???????
jaundice
Registration Number
IRCT20211218053444N1
Lead Sponsor
Kerman University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
150
Inclusion Criteria

Weight 1000 to 1500 grams
Failure to receive previous phototherapy
Need to receive phototherapy
Age less than 24 hours

Exclusion Criteria

Known hemolytic disease
Asphyxia
Non-bacterial infection overt
Existence of major anomalies
Unstable conditions (arterial blood pH less than 6.8 for more than 2 hours, stable bradycardia associated with hypoxia for more than 2 hours)
Unwanted consent of the baby's parents or legal guardian to enter the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eonatal jaundice rate. Timepoint: Fourteen days. Method of measurement: Serum bilirubin levels.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath